The ADIPOQ 45 T > G variant has been shown to be associated with variability in adiponectin levels in several studies including in overweight Finish subjects with impaired glucose tolerance [12], diabetic and non-diabetic Brazilian patients with high cardiovascular risk [15], Arab patients with acute coronary syndrome [30]. This evidence concerns the gene ADIPOQ and Impaired glucose tolerance.